Cellect Biotechnology Ltd. (APOP) Forms $9.06 Double Bottom; 12 Analysts Bullish Taylor Wimpey plc (LON:TW)

Among 21 analysts covering Taylor Wimpey PLC (LON:TW), 12 have Buy rating, 1 Sell and 8 Hold. Therefore 57% are positive. Taylor Wimpey PLC had 226 analyst reports since July 24, 2015 according to SRatingsIntel. Canaccord Genuity maintained it with “Buy” rating and GBX 210 target in Wednesday, February 3 report. The firm has “Hold” rating by Liberum Capital given on Wednesday, January 3. The firm has “Hold” rating by Shore Capital given on Tuesday, February 28. The company was maintained on Monday, July 31 by Deutsche Bank. The firm has “Overweight” rating given on Friday, September 29 by JP Morgan. The company was maintained on Wednesday, May 31 by Deutsche Bank. Deutsche Bank maintained Taylor Wimpey plc (LON:TW) on Wednesday, March 2 with “Buy” rating. The company was maintained on Friday, September 16 by Deutsche Bank. As per Friday, February 17, the company rating was maintained by Deutsche Bank. The rating was maintained by Deutsche Bank with “Buy” on Monday, May 9. See Taylor Wimpey plc (LON:TW) latest ratings:

10/01/2018 Broker: Numis Securities Rating: Hold New Target: GBX 221.00 Downgrade
10/01/2018 Broker: Shore Capital Rating: Hold Maintain
10/01/2018 Broker: Peel Hunt Rating: Hold Old Target: GBX 210.00 New Target: GBX 210.00 Downgrade
10/01/2018 Broker: Liberum Capital Rating: Hold Old Target: GBX 200.00 New Target: GBX 200.00 Maintain
08/01/2018 Broker: JP Morgan Rating: Overweight Old Target: GBX 220.00 New Target: GBX 220.00 Maintain
08/01/2018 Broker: Liberum Capital Rating: Hold Old Target: GBX 200.00 New Target: GBX 200.00 Maintain
05/01/2018 Broker: Peel Hunt Rating: Add Old Target: GBX 210.00 New Target: GBX 210.00 Maintain
03/01/2018 Broker: Liberum Capital Rating: Hold Old Target: GBX 181.00 New Target: GBX 200.00 Maintain
18/12/2017 Broker: Deutsche Bank Rating: Buy Old Target: GBX 246.00 New Target: GBX 246.00 Maintain
14/12/2017 Broker: JP Morgan Rating: Overweight Old Target: GBX 210.00 New Target: GBX 220.00 Maintain

Cellect Biotechnology Ltd. (APOP) formed double bottom with $8.79 target or 3.00% below today’s $9.06 share price. Cellect Biotechnology Ltd. (APOP) has $54.38M valuation. The stock increased 1.12% or $0.1 during the last trading session, reaching $9.06. About 77,006 shares traded. Cellect Biotechnology Ltd. (NASDAQ:APOP) has 0.00% since January 27, 2017 and is . It has underperformed by 16.70% the S&P500.

Analysts await Cellect Biotechnology Ltd. (NASDAQ:APOP) to report earnings on March, 22. They expect $-0.31 earnings per share, down 3,000.00% or $0.30 from last year’s $-0.01 per share. After $-0.39 actual earnings per share reported by Cellect Biotechnology Ltd. for the previous quarter, Wall Street now forecasts -20.51% EPS growth.

The stock increased 1.22% or GBX 2.4 during the last trading session, reaching GBX 199.3. About 11.54M shares traded. Taylor Wimpey plc (LON:TW) has 0.00% since January 27, 2017 and is . It has underperformed by 16.70% the S&P500.

Taylor Wimpey plc operates as a homebuilding firm in the United Kingdom and Spain. The company has market cap of 6.50 billion GBP. It manufactures various homes, such as one- and two-bedroom apartments, and five-bedroom detached houses. It has a 12.15 P/E ratio.

Free Email Newsletter

Enter your email address below to get the latest news and analysts’ ratings for your stocks with our free daily email newsletter: